These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11798975)

  • 41. Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women.
    Park WI; Kim SS; Chung HR; Shin SY; Lee JY
    Fertil Steril; 2004 Apr; 81(4):1067-72. PubMed ID: 15066465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hyperprolactinemia and disorders of the menstrual cycle].
    Topalski-Fistes N; Bujas M; Maticki-Sekulić M; Suvacarev S
    Med Pregl; 1999; 52(3-5):156-61. PubMed ID: 10518402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization.
    Luna M; Grunfeld L; Mukherjee T; Sandler B; Copperman AB
    Fertil Steril; 2007 Apr; 87(4):782-7. PubMed ID: 17207802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are follicle stimulating hormone measurements predictive of ovarian response to hyperstimulation with human menopausal gonadotrophin?
    Oghoetuoma J; Polson DW; Troup SA; Lieberman BA
    J Obstet Gynaecol; 1997 Mar; 17(2):188-91. PubMed ID: 15511819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeated testing of basal FSH levels has no predictive value for IVF outcome in women with elevated basal FSH.
    Abdalla H; Thum MY
    Hum Reprod; 2006 Jan; 21(1):171-4. PubMed ID: 16155077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of follicle-stimulating hormone test to predict poor response in in vitro fertilization.
    Iwase A; Ando H; Kuno K; Mizutani S
    Obstet Gynecol; 2005 Mar; 105(3):645-52. PubMed ID: 15738039
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
    Gómez R; Lima I; Simón C; Pellicer A
    Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.
    Balasch J; Fábregues F; Peñarrubia J; Carmona F; Casamitjana R; Creus M; Manau D; Casals G; Vanrell JA
    Hum Reprod; 2006 Jul; 21(7):1884-93. PubMed ID: 16517559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome.
    Noci I; Maggi M; Fuzzi B; Biagiotti R; Ricci F; Marchionni M
    Gynecol Endocrinol; 2000 Oct; 14(5):321-6. PubMed ID: 11109971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
    Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
    Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction.
    Weghofer A; Margreiter M; Fauster Y; Schaetz T; Brandstetter A; Boehm D; Feichtinger W
    Hum Reprod; 2005 Sep; 20(9):2448-52. PubMed ID: 15905294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome.
    Barroso G; Oehninger S; Monzó A; Kolm P; Gibbons WE; Muasher SJ
    J Assist Reprod Genet; 2001 Sep; 18(9):499-505. PubMed ID: 11665665
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation.
    Mukherjee T; Copperman AB; Lapinski R; Sandler B; Bustillo M; Grunfeld L
    Fertil Steril; 1996 Mar; 65(3):588-93. PubMed ID: 8774292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
    Zhao JZ; Ye BL; Lin JJ; Lin WQ; Chi HH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep; 38(9):545-8. PubMed ID: 14680609
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Carmona F; Casamitjana R; Vanrell JA; Balasch J
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Value of basal serum gonadotropin levels in the diagnosis of precocious puberty in girls].
    Liang JT
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):942-5. PubMed ID: 23234783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.